Braun M Y, McCormack A, Webb G, Batchelor J R
Department of Immunology, Royal Postgraduate Medical School, Hammersmith Hospital, London.
Eur J Immunol. 1993 Jul;23(7):1462-8. doi: 10.1002/eji.1830230710.
The main stimulus triggering early acute allograft rejection is known to be delivered by the allogeneic "passenger" leukocytes present within the grafts. Once these cells have been replaced by cells of recipient origin, subsequent rejection episodes are generally less frequent and less acutely destructive. How this replacement affects the cell populations responsible for allograft rejection is not known. Here we report that rat alloreactive non-cytotoxic AS (RT1I) anti-August (RT1c) CD4+ T cells, that were shown to be specific for RT1.Bc+ August spleen stimulators, were able to cause acute rejection of normal August kidney allografts transplanted into sublethally irradiated AS recipients. These cells, however, failed to reject passenger cell-depleted (PCD) August kidneys, despite the substantial expression of RT1.Bc+ products on the graft tubular epithelium. In experiments in vitro, August kidney tubular epithelial cells expressing RT1.Bc+ antigens were found to be unable to stimulate the alloreactive T cells to proliferate. Moreover, preincubation with class II-positive August kidney epithelial cells specifically abrogated the alloreactivity of the T cells. Adding recombinant interleukin-2, however, restored the response to alloantigens. These results are consistent with the hypothesis that T cell populations capable of mediating early acute allograft rejection are different from those mediating late rejection, when donor passenger leukocytes are no longer present. They also suggest clonal anergy as one of the mechanisms responsible for maintaining long-term transplantation tolerance.
已知引发早期急性移植排斥反应的主要刺激因素是由移植物中存在的同种异体“过客”白细胞传递的。一旦这些细胞被受体来源的细胞所取代,随后的排斥反应通常就不那么频繁,破坏性也没那么大。这种替代如何影响负责移植排斥反应的细胞群体尚不清楚。在此,我们报告大鼠同种异体反应性非细胞毒性AS(RT1I)抗奥古斯塔(RT1c)CD4 + T细胞,已证明其对RT1.Bc +奥古斯塔脾脏刺激物具有特异性,能够导致移植到亚致死剂量照射的AS受体中的正常奥古斯塔肾同种异体移植发生急性排斥反应。然而,尽管移植肾小管上皮细胞上大量表达RT1.Bc +产物,这些细胞却未能排斥无过客细胞(PCD)的奥古斯塔肾。在体外实验中,发现表达RT1.Bc +抗原的奥古斯塔肾小管上皮细胞无法刺激同种异体反应性T细胞增殖。此外,与II类阳性奥古斯塔肾上皮细胞预孵育可特异性消除T细胞的同种异体反应性。然而,添加重组白细胞介素-2可恢复对同种异体抗原的反应。这些结果与以下假设一致,即当供体过客白细胞不再存在时,能够介导早期急性移植排斥反应的T细胞群体与介导晚期排斥反应的T细胞群体不同。它们还表明克隆无能是维持长期移植耐受的机制之一。